SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing a flurry of community discussion as the price hovers near key resistance levels, with many traders anticipating a breakout toward 80k. Sentiment is currently divided between bullish optimism driven by institutional ETF inflows and institutional buying, and caution regarding market volatility and geopolitical headlines.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing an unprecedented, parabolic rally driven by intense AI-sector optimism, historic institutional buying, and a record-breaking streak of consecutive green days. The community is deeply polarized, with bulls emboldened by sustained momentum and massive gains, while bears are increasingly vocal about the lack of fundamental justification, citing extreme technical overextension and looming recession risks as signs that a sharp correction is imminent.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying as investors pile into the stock following confirmation of a significant order from Celestial AI, which was recently acquired by Marvell, fueling excitement about the company's role in the AI infrastructure supply chain. The community is actively discussing the stock's parabolic price action and its potential for a short squeeze, with many retail holders dismissing recent bearish short reports while eagerly anticipating potential partnerships with hyperscalers.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is capturing attention as community members debate whether the asset is primed for a breakout or trapped in a stagnant consolidation phase, with frequent comparisons to other trending memecoins. Conversations are dominated by retail investors balancing long-term optimism regarding future utility with frustration over the lack of significant momentum.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Advanced Micro Devices is surging alongside the broader semiconductor sector, fueled by intense investor focus on the data center and CPU demand cycle that has also boosted Intel and other chip stocks. Community discussions highlight strong bullish sentiment driven by AI momentum, though many participants are debating whether the current parabolic price action and record-high RSI levels indicate a sustainable secular rally or a vulnerable, overbought bubble.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently surging and trending as a major short squeeze candidate following the FDA's decision to lift clinical holds on its key heart disease trial, a move that fundamentally de-risks its gene-editing pipeline. The community is focused on the massive short interest and the potential for a significant rally as traders weigh this regulatory win against an upcoming Phase 3 readout for its hereditary angioedema therapy.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as frustrated investors react to a record-breaking rally in the semiconductor sector that has left bearish positions heavily underwater. Community discourse is dominated by intense debates over volatility decay, the sustainability of the sector's parabolic growth, and tactical strategies for managing leveraged ETF risk amidst widespread calls for an imminent pullback.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is trending as traders closely watch the stock's tight correlation with Bitcoin's momentum and navigate the impact of regulatory scrutiny from a recent New York lawsuit. Community discussions are heavily focused on the stock's technical struggle at key resistance levels and speculative potential for a breakout driven by upcoming legislative developments in crypto policy.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is trending as community members closely watch its pivot toward AI and high-performance computing data centers, with many traders actively discussing the potential for a gamma squeeze fueled by crypto-linked momentum. While some investors remain skeptical of the stock's performance compared to peers, others are highlighting its infrastructure capacity and power assets as a strategic advantage that could drive future volatility.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

iShares Semiconductor ETF is currently at the center of heated market debate as it maintains a historic winning streak, with investors fiercely divided between those capitalizing on AI-driven momentum and others bracing for a potential blow-off top. Community discussion remains dominated by high-stakes speculation, with many traders actively debating whether to ride the rally or position for a severe mean reversion amid significant volatility in the sector.

statis crypto Watchlist

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biomea Fusion (NASDAQ:BMEA) Receives Buy Rating from D. Boral Capital

D. Boral Capital restated a "buy" rating and issued a $12.00 price objective on shares of Biomea Fusion in a research note on Wednesday...

Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Biomea Fusion, Inc. (NASDAQ:BMEA - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine ratings firms that are covering the company, Marketbeat reports. One investment...

Biomea Fusion Details Icovamenib Diabetes Milestones, Teases BMF-650 Obesity Readouts

Executives from Biomea Fusion (NASDAQ:BMEA) discussed the company's lead diabetes program, icovamenib, and outlined near-term clinical milestones during a recent company event hosted by an operator...

Biomea Fusion Teases Q2 Phase 1 Data for Oral GLP-1 BMF-650, Advances Icovamenib in Diabetes

Biomea Fusion (NASDAQ:BMEA) outlined several near-term clinical milestones and development priorities during a JPMorgan conference call, with executives emphasizing upcoming Phase I data for its oral GLP-1 receptor agonist candidate BMF-650 and continued advancement of icovamenib in diabetes.

BMF-6...

Biomea Fusion (NASDAQ:BMEA) Upgraded by Wall Street Zen to Hold Rating

Wall Street Zen upgraded shares of Biomea Fusion from a "sell" rating to a "hold" rating in a report on Saturday...

Biomea Fusion (NASDAQ:BMEA) Price Target Raised to $7.00 at Citigroup

Citigroup increased their price objective on Biomea Fusion from $6.00 to $7.00 and gave the stock a "buy" rating in a report on Friday...

HC Wainwright Comments on Biomea Fusion Q1 Earnings

Biomea Fusion, Inc. (NASDAQ:BMEA - Free Report) - Equities researchers at HC Wainwright issued their Q1 2026 earnings estimates for Biomea Fusion in a research report issued to clients and investors...

Biomea Fusion's (BMEA) Buy Rating Reaffirmed at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $12.00 target price on shares of Biomea Fusion in a research report on Wednesday...

Biomea Fusion (NASDAQ:BMEA) Issues Quarterly Earnings Results

Biomea Fusion (NASDAQ:BMEA - Get Free Report) released its quarterly earnings data on Tuesday. The company reported $0.27 EPS for the quarter, beating analysts' consensus estimates of ($0.25) by...

Biomea Fusion (BMEA) Expected to Announce Quarterly Earnings on Monday

Biomea Fusion (NASDAQ:BMEA) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-biomea-fusion-inc-stock...

This account has been verified as an official BMEA representative.

Verified Account

Biomea Fusion IR

Biomea Fusion, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic disorders, such as diabetes. It offers its lead product candidate, BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company was founded by Thomas Butler and Ramses Erdtmann in August 2017 and is headquartered in San Carlos, CA.

BMEA
Biomea Fusion Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BMEA News

BMEABiomea Fusion Inc